Biotech startup wants to give pharma giants new hope in the fight against brain disease
Scientists Brian Della Valle and Casper Hampel believe they have found a biomarker that can identify neurological diseases such as multiple sclerosis, Alzheimer's and Parkinson's disease earlier than ever before. They have now launched a company to bring their discovery to the industry.
BY KEVIN GRØNNEMANN
A brand new startup founded by two scientists from Aarhus University and the Technical University of Denmark hopes to play a crucial role in the development of medicines that can treat complicated neurological diseases like Alzheimer's, Parkinson's and multiple sclerosis.
Allerede abonnent?Log ind her
Læs hele artiklen
Få adgang i 14 dage for 0 kr. Det kræver intet kreditkort, og du vil ikke overgå til et betalt abonnement efterfølgende.
